Global Information
회사소개 | 문의 | 비교리스트
SALE

세계의 렘데시비르(Remdesivir) 시장 : 제형별, 투여 경로별, 환자 연령별, 적응증별, 유통채널별, 지역별, 경쟁 예측, 기회(-2026년)

Global Remdesivir Market, By Dosage Form, By Route of Administration, By Patient Age, By Application (SARS-CoV-2, MERS-CoV, Ebola, SARS-CoV), By Distribution Channel, By Region, Competition Forecast & Opportunities, 2026

리서치사 TechSci Research
발행일 2021년 08월 상품 코드 1021830
페이지 정보 영문 114 Pages
가격
US $ 4,900 US $ 4,400 ₩ 5,228,000 Unprintable PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste 가 되지 않으며, 인쇄 또한 불가능합니다.
US $ 5,900 ₩ 7,011,000 PDF and Excel (Multi-User License)
US $ 8,900 ₩ 10,576,000 PDF and Excel (Custom Research License)

TechSci Research 보고서는 10% Customization 서비스가 포함되어 있습니다. 보고서에 포함돼 있지 않은 리서치 데이터와 시장 동향을 추가적으로 요청할 수 있습니다. 자세한 사항은 문의하여 주시기 바랍니다.



세계의 렘데시비르(Remdesivir) 시장 : 제형별, 투여 경로별, 환자 연령별, 적응증별, 유통채널별, 지역별, 경쟁 예측, 기회(-2026년) Global Remdesivir Market, By Dosage Form, By Route of Administration, By Patient Age, By Application (SARS-CoV-2, MERS-CoV, Ebola, SARS-CoV), By Distribution Channel, By Region, Competition Forecast & Opportunities, 2026
발행일 : 2021년 08월 페이지 정보 : 영문 114 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계 렘데시비르 시장은 2026년까지 99억 1,338만 달러에 달할 것으로 예측됩니다. 세계 렘데시비르 시장은 다양한 지역에서의 COVID-19 팬데믹에 의해 성장이 촉진되고 있습니다. 렘데시비르는 세계 각지의 COVID-19 환자 치료에 유효한 것으로 확인되었습니다.

세계의 렘데시비르(Remdesivir) 시장에 대해 조사분석했으며, 시장 규모·점유율·예측, 부문별 분석, 경쟁 분석, 시장 동향 변화, 새로운 기회에 대한 정보를 전해드립니다.

목차

제1장 제품 개요

제2장 조사 방법

제3장 세계 렘데시비르(Remdesivir) 시장에 대한 COVID-19의 영향

제4장 개요

제5장 고객의 소리(VOC)

제6장 세계의 렘데시비르 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제형별(동결건조 용액, 동결 용액)
    • 투여 경로별(정맥내, 흡입)
    • 환자 연령별(고령자, 성인, 소아)
    • 적응증별(SARS-CoV-2(COVID-19) , MERS-CoV, 에볼라, SARS-CoV)
    • 유통채널별(병원, 진료소, 드럭스토어, 약국)
    • 기업별
    • 지역별
  • 제품 시장 맵

제7장 북미의 렘데시비르 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제형별
    • 투여 경로별
    • 환자 연령별
    • 적응증별
    • 유통채널별
    • 국가별
  • 북미 : 국가별 분석
    • 미국의 렘데시비르 시장 전망
    • 멕시코의 렘데시비르 시장 전망
    • 캐나다의 렘데시비르 시장 전망

제8장 아시아태평양의 렘데시비르 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제형별
    • 투여 경로별
    • 환자 연령별
    • 적응증별
    • 유통채널별
    • 국가별
  • 아시아태평양 : 국가별 분석
    • 인도의 렘데시비르 시장 전망
    • 일본의 렘데시비르 시장 전망
    • 중국의 렘데시비르 시장 전망
    • 한국의 렘데시비르 시장 전망
    • 호주의 렘데시비르 시장 전망

제9장 유럽의 렘데시비르 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제형별
    • 투여 경로별
    • 환자 연령별
    • 적응증별
    • 유통채널별
    • 국가별
  • 유럽 : 국가별 분석
    • 프랑스의 렘데시비르 시장 전망
    • 영국의 렘데시비르 시장 전망
    • 이탈리아의 렘데시비르 시장 전망
    • 독일의 렘데시비르 시장 전망
    • 스페인의 렘데시비르 시장 전망

제10장 남미의 렘데시비르 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제형별
    • 투여 경로별
    • 환자 연령별
    • 적응증별
    • 유통채널별
    • 국가별
  • 남미 : 국가별 분석
    • 브라질의 렘데시비르 시장 전망
    • 아르헨티나의 렘데시비르 시장 전망
    • 콜롬비아의 렘데시비르 시장 전망

제11장 중동 및 아프리카의 렘데시비르 시장 전망

  • 시장 규모와 예측
    • 금액별
  • 시장 점유율과 예측
    • 제형별
    • 투여 경로별
    • 환자 연령별
    • 적응증별
    • 유통채널별
    • 국가별
  • 중동 및 아프리카 : 국가별 분석
    • 이란의 렘데시비르 시장 전망
    • 남아프리카공화국의 렘데시비르 시장 전망
    • 아랍에미리트(UAE)의 렘데시비르 시장 전망
    • 사우디아라비아의 렘데시비르 시장 전망
    • 쿠웨이트의 렘데시비르 시장 전망

제12장 시장 역학

  • 성장 촉진요인
  • 과제

제13장 시장 동향과 발전

제14장 가격 분석

제15장 특허 분석

제16장 경쟁 구도

  • Gilead Sciences, Inc.
  • Cipla Ltd.
  • Hetero Labs Ltd.
  • Meda Pharma SA(VIATRIS Pharmaceuticals Ltd.)
  • Dr Reddy's Laboratories Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Cadila Healthcare Ltd.
  • Jubilant Pharmova Ltd.
  • Eva Pharma Ltd.
  • Ferozsons Laboratories

제17장 전략적 제안

제18장 출판사/면책사항

LSH 21.09.03

List of Figures

  • Figure 1: Global Remdesivir Market Size, By Value (USD Million), 2020-2026F
  • Figure 2: Global Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
  • Figure 3: Global Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 4: Global Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
  • Figure 5: Global Remdesivir Market Share, By Application, By Value, 2020-2026F
  • Figure 6: Global Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
  • Figure 7: Global Remdesivir Market Share, By Company, By Value, 2020
  • Figure 8: Global Remdesivir Market Share, By Region, By Value, 2020-2026F
  • Figure 9: Global Remdesivir Product Market Map, By Value, 2020-2026F
  • Figure 10: North America Remdesivir Market Size, By Value (USD Million), 2020-2026F
  • Figure 11: North America Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
  • Figure 12: North America Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 13: North America Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
  • Figure 14: North America Remdesivir Market Share, By Application, By Value, 2020-2026F
  • Figure 15: North America Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
  • Figure 16: North America Remdesivir Market Share, By Country, By Value, 2020-2026F
  • Figure 17: United States Remdesivir Market Size, By Value (USD Million), 2020-2026F
  • Figure 18: United States Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
  • Figure 19: United States Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 20: United States Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
  • Figure 21: United States Remdesivir Market Share, By Application, By Value, 2020-2026F
  • Figure 22: United States Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
  • Figure 23: Mexico Remdesivir Market Size, By Value (USD Million), 2020-2026F
  • Figure 24: Mexico Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
  • Figure 25: Mexico Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 26: Mexico Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
  • Figure 27: Mexico Remdesivir Market Share, By Application, By Value, 2020-2026F
  • Figure 28: Mexico Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
  • Figure 29: Canada Remdesivir Market Size, By Value (USD Million), 2020-2026F
  • Figure 30: Canada Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
  • Figure 31: Canada Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 32: Canada Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
  • Figure 33: Canada Remdesivir Market Share, By Application, By Value, 2020-2026F
  • Figure 34: Canada Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
  • Figure 35: Asia-Pacific Remdesivir Market Size, By Value (USD Million), 2020-2026F
  • Figure 36: Asia-Pacific Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
  • Figure 37: Asia-Pacific Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 38: Asia-Pacific Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
  • Figure 39: Asia-Pacific Remdesivir Market Share, By Application, By Value, 2020-2026F
  • Figure 40: Asia-Pacific Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
  • Figure 41: Asia-Pacific Remdesivir Market Share, By Country, By Value, 2020-2026F
  • Figure 42: India Remdesivir Market Size, By Value (USD Million), 2020-2026F
  • Figure 43: India Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
  • Figure 44: India Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 45: India Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
  • Figure 46: India Remdesivir Market Share, By Application, By Value, 2020-2026F
  • Figure 47: India Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
  • Figure 48: Japan Remdesivir Market Size, By Value (USD Million), 2020-2026F
  • Figure 49: Japan Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
  • Figure 50: Japan Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 51: Japan Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
  • Figure 52: Japan Remdesivir Market Share, By Application, By Value, 2020-2026F
  • Figure 53: Japan Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
  • Figure 54: China Remdesivir Market Size, By Value (USD Million), 2020-2026F
  • Figure 55: China Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
  • Figure 56: China Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 57: China Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
  • Figure 58: China Remdesivir Market Share, By Application, By Value, 2020-2026F
  • Figure 59: China Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
  • Figure 60: South Korea Remdesivir Market Size, By Value (USD Million), 2020-2026F
  • Figure 61: South Korea Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
  • Figure 62: South Korea Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 63: South Korea Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
  • Figure 64: South Korea Remdesivir Market Share, By Application, By Value, 2020-2026F
  • Figure 65: South Korea Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
  • Figure 66: Australia Remdesivir Market Size, By Value (USD Million), 2020-2026F
  • Figure 67: Australia Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
  • Figure 68: Australia Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 69: Australia Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
  • Figure 70: Australia Remdesivir Market Share, By Application, By Value, 2020-2026F
  • Figure 71: Australia Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
  • Figure 72: Europe Remdesivir Market Size, By Value (USD Million), 2020-2026F
  • Figure 73: Europe Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
  • Figure 74: Europe Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 75: Europe Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
  • Figure 76: Europe Remdesivir Market Share, By Application, By Value, 2020-2026F
  • Figure 77: Europe Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
  • Figure 78: Europe Remdesivir Market Share, By Country, By Value, 2020-2026F
  • Figure 79: France Remdesivir Market Size, By Value (USD Million), 2020-2026F
  • Figure 80: France Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
  • Figure 81: France Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 82: France Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
  • Figure 83: France Remdesivir Market Share, By Application, By Value, 2020-2026F
  • Figure 84: France Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
  • Figure 85: United Kingdom Remdesivir Market Size, By Value (USD Million), 2020-2026F
  • Figure 86: United Kingdom Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
  • Figure 87: United Kingdom Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 88: United Kingdom Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
  • Figure 89: United Kingdom Remdesivir Market Share, By Application, By Value, 2020-2026F
  • Figure 90: United Kingdom Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
  • Figure 91: Italy Remdesivir Market Size, By Value (USD Million), 2020-2026F
  • Figure 92: Italy Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
  • Figure 93: Italy Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 94: Italy Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
  • Figure 95: Italy Remdesivir Market Share, By Application, By Value, 2020-2026F
  • Figure 96: Italy Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
  • Figure 97: Germany Remdesivir Market Size, By Value (USD Million), 2020-2026F
  • Figure 98: Germany Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
  • Figure 99: Germany Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 100: Germany Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
  • Figure 101: Germany Remdesivir Market Share, By Application, By Value, 2020-2026F
  • Figure 102: Germany Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
  • Figure 103: Spain Remdesivir Market Size, By Value (USD Million), 2020-2026F
  • Figure 104: Spain Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
  • Figure 105: Spain Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 106: Spain Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
  • Figure 107: Spain Remdesivir Market Share, By Application, By Value, 2020-2026F
  • Figure 108: Spain Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
  • Figure 109: South America Remdesivir Market Size, By Value (USD Million), 2020-2026F
  • Figure 110: South America Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
  • Figure 111: South America Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 112: South America Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
  • Figure 113: South America Remdesivir Market Share, By Application, By Value, 2020-2026F
  • Figure 114: South America Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
  • Figure 115: South America Remdesivir Market Share, By Country, By Value, 2020-2026F
  • Figure 116: Brazil Remdesivir Market Size, By Value (USD Million), 2020-2026F
  • Figure 117: Brazil Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
  • Figure 118: Brazil Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 119: Brazil Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
  • Figure 120: Brazil Remdesivir Market Share, By Application, By Value, 2020-2026F
  • Figure 121: Brazil Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
  • Figure 122: Argentina Remdesivir Market Size, By Value (USD Million), 2020-2026F
  • Figure 123: Argentina Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
  • Figure 124: Argentina Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 125: Argentina Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
  • Figure 126: Argentina Remdesivir Market Share, By Application, By Value, 2020-2026F
  • Figure 127: Argentina Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
  • Figure 128: Colombia Remdesivir Market Size, By Value (USD Million), 2020-2026F
  • Figure 129: Colombia Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
  • Figure 130: Colombia Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 131: Colombia Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
  • Figure 132: Colombia Remdesivir Market Share, By Application, By Value, 2020-2026F
  • Figure 133: Colombia Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
  • Figure 134: Middle East and Africa Remdesivir Market Size, By Value (USD Million), 2020-2026F
  • Figure 135: Middle East and Africa Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
  • Figure 136: Middle East and Africa Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 137: Middle East and Africa Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
  • Figure 138: Middle East and Africa Remdesivir Market Share, By Application, By Value, 2020-2026F
  • Figure 139: Middle East and Africa Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
  • Figure 140: Middle East and Africa Remdesivir Market Share, By Country, By Value, 2020-2026F
  • Figure 141: Iran Remdesivir Market Size, By Value (USD Million), 2020-2026F
  • Figure 142: Iran Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
  • Figure 143: Iran Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 144: Iran Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
  • Figure 145: Iran Remdesivir Market Share, By Application, By Value, 2020-2026F
  • Figure 146: Iran Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
  • Figure 147: South Africa Remdesivir Market Size, By Value (USD Million), 2020-2026F
  • Figure 148: South Africa Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
  • Figure 149: South Africa Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 150: South Africa Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
  • Figure 151: South Africa Remdesivir Market Share, By Application, By Value, 2020-2026F
  • Figure 152: South Africa Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
  • Figure 153: UAE Remdesivir Market Size, By Value (USD Million), 2020-2026F
  • Figure 154: UAE Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
  • Figure 155: UAE Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 156: UAE Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
  • Figure 157: UAE Remdesivir Market Share, By Application, By Value, 2020-2026F
  • Figure 158: UAE Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
  • Figure 159: Saudi Arabia Remdesivir Market Size, By Value (USD Million), 2020-2026F
  • Figure 160: Saudi Arabia Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
  • Figure 161: Saudi Arabia Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 162: Saudi Arabia Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
  • Figure 163: Saudi Arabia Remdesivir Market Share, By Application, By Value, 2020-2026F
  • Figure 164: Saudi Arabia Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
  • Figure 165: Kuwait Remdesivir Market Size, By Value (USD Million), 2020-2026F
  • Figure 166: Kuwait Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
  • Figure 167: Kuwait Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
  • Figure 168: Kuwait Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
  • Figure 169: Kuwait Remdesivir Market Share, By Application, By Value, 2020-2026F
  • Figure 170: Kuwait Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F

Global Remdesivir market is expected to reach USD9913.38 million by 2026. Remdesivir, a drug originally developed by Gilead Sciences, Inc. for the treatment of Ebola, is an antiviral medication belonging to the drug class of protease inhibitors. Remdesivir is a nucleotide analog particularly of adenosine, which shuts down the viral replication process by inhibiting the activity of an important viral enzyme RNA-dependent RNA polymerase. The drug basically causes mutation in viral genome and blocks polymerase enzymes function, which brings about premature termination of viral replication.

The global remdesivir market is driven by the increasing prevalence of COVID-19 pandemic across different parts of the globe. Remdesivir has been found to be effective in treating novel coronavirus disease patients across different parts of the globe. The Chinese have also been using the drug on compassionate use basis. Additionally, the drug was also used on the very first COVID-19 patient in the US, a young man in Snohomish country in Washington. He was given the drug when his condition worsened, and signs of improvement were observed on the very next day in his condition after the drug administration. A Californian patient, who the doctors thought, will not survive, also recovered after getting remdesivir. Promising results were also observed in Japan on 14 patients. After such cases and evidences, the US Food and Drug Administration granted approval to Remdesivir in Oct 2020 and the world is hoping that it will emerge out as a successful coronavirus treatment in coming years as well.

The global remdesivir market is segmented based on dosage form, route of administration, patient age, distribution channel, application, company, and region. Based on dosage form, the market can be categorized into frozen solution, and lyophilized solution. The lyophilized segment is expected to hold significant market share on account of their longer shelf life. Additionally, they are cost effective, safe and an effective way to deliver medication.

Regionally, Asia Pacific is expected to witness significant growth during the forecast period in the overall remdesivir market owing to increasing number of COVID-19 patients and huge number of hospitalization cases along with increasing demand for remdesivir for the treatment of COVID-19.

Major players operating in the global remdesivir market include Gilead Sciences, Inc., Cipla Ltd., Hetero Labs Ltd., Meda Pharma SA (VIATRIS Pharmaceuticals Ltd.), Dr Reddy's Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cadila Healthcare Ltd., Jubilant Pharmova Ltd., Eva Pharma, Ferozsons Laboratories and others.

Years considered for this report:

Base Year: 2020

Estimated Year: 2021E

Forecast Period: 2022F-2026F

Objective of the Study:

  • To analyze and estimate the market size of global remdesivir market in 2020.
  • To estimate and forecast the market size of global remdesivir market from 2021 to 2026 and growth rate until 2026.
  • To classify and forecast global remdesivir market based on dosage form, route of administration, patient age, application, distribution channel, company, and regional distribution.
  • To identify dominant region or segment in the global remdesivir market.
  • To identify drivers and challenges for global remdesivir market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global remdesivir market.
  • To conduct pricing analysis for global remdesivir market.
  • To identify and analyze the profile of leading players operating in global remdesivir market.
  • To identify key sustainable strategies adopted by market players in global remdesivir market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global remdesivir market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Remdesivir manufacturers, suppliers, distributors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to remdesivir
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global remdesivir market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Remdesivir Market, By Dosage Form:

Lyophilized Solution

Frozen Solution

  • Global Remdesivir Market, By Route of Administration:

Intravenous

Inhalation

  • Global Remdesivir Market, By Patient Age:

Geriatric

Adult

Pediatric

  • Global Remdesivir Market, By Application:

SARS-CoV-2 (COVID-19)

MERS-CoV

Ebola

SARS-CoV

  • Global Remdesivir Market, By Distribution Channel:

Hospitals

Clinics

Drug Stores and Pharmacies

  • Global Remdesivir Market, By Region:

North America

  • United States
  • Mexico
  • Canada

Asia-Pacific

  • India
  • Japan
  • China
  • South Korea
  • Australia

Europe

  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain

South America

  • Brazil
  • Argentina
  • Colombia

Middle East & Africa

  • Iran
  • South Africa
  • UAE
  • Saudi Arabia
  • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global remdesivir market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Remdesivir Market

4. Executive Summary

5. Voice of Customer

  • 5.1. Brand Awareness (Aided/Unaided)
  • 5.2. Product Awareness
  • 5.3. Customer Satisfaction Analysis
  • 5.4. Unmet Needs/Challenges

6. Global Remdesivir Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Dosage Form (Lyophilized Solution, Frozen Solution)
    • 6.2.2. By Route of Administration (Intravenous, Inhalation)
    • 6.2.3. By Patient Age (Geriatric, Adult, Pediatric)
    • 6.2.4. By Application (SARS-CoV-2 (COVID-19), MERS-CoV, Ebola, SARS-CoV)
    • 6.2.5. By Distribution Channel (Hospitals, Clinics, Drug Stores and Pharmacies)
    • 6.2.6. By Company (2020)
    • 6.2.7. By Region
  • 6.3. Product Market Map

7. North America Remdesivir Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Dosage Form
    • 7.2.2. By Route of Administration
    • 7.2.3. By Patient Age
    • 7.2.4. By Application
    • 7.2.5. By Distribution Channel
    • 7.2.6. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Remdesivir Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Dosage Form
        • 7.3.1.2.2. By Route of Administration
        • 7.3.1.2.3. By Patient Age
        • 7.3.1.2.4. By Application
        • 7.3.1.2.5. By Distribution Channel
    • 7.3.2. Mexico Remdesivir Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Dosage Form
        • 7.3.2.2.2. By Route of Administration
        • 7.3.2.2.3. By Patient Age
        • 7.3.2.2.4. By Application
        • 7.3.2.2.5. By Distribution Channel
    • 7.3.3. Canada Remdesivir Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Dosage Form
        • 7.3.3.2.2. By Route of Administration
        • 7.3.3.2.3. By Patient Age
        • 7.3.3.2.4. By Application
        • 7.3.3.2.5. By Distribution Channel

8. Asia-Pacific Remdesivir Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Dosage Form
    • 8.2.2. By Route of Administration
    • 8.2.3. By Patient Age
    • 8.2.4. By Application
    • 8.2.5. By Distribution Channel
    • 8.2.6. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. India Remdesivir Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Dosage Form
        • 8.3.1.2.2. By Route of Administration
        • 8.3.1.2.3. By Patient Age
        • 8.3.1.2.4. By Application
        • 8.3.1.2.5. By Distribution Channel
    • 8.3.2. Japan Remdesivir Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Dosage Form
        • 8.3.2.2.2. By Route of Administration
        • 8.3.2.2.3. By Patient Age
        • 8.3.2.2.4. By Application
        • 8.3.2.2.5. By Distribution Channel
    • 8.3.3. China Remdesivir Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Dosage Form
        • 8.3.3.2.2. By Route of Administration
        • 8.3.3.2.3. By Patient Age
        • 8.3.3.2.4. By Application
        • 8.3.3.2.5. By Distribution Channel
    • 8.3.4. South Korea Remdesivir Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Dosage Form
        • 8.3.4.2.2. By Route of Administration
        • 8.3.4.2.3. By Patient Age
        • 8.3.4.2.4. By Application
        • 8.3.4.2.5. By Distribution Channel
    • 8.3.5. Australia Remdesivir Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Dosage Form
        • 8.3.5.2.2. By Route of Administration
        • 8.3.5.2.3. By Patient Age
        • 8.3.5.2.4. By Application
        • 8.3.5.2.5. By Distribution Channel

9. Europe Remdesivir Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Dosage Form
    • 9.2.2. By Route of Administration
    • 9.2.3. By Patient Age
    • 9.2.4. By Application
    • 9.2.5. By Distribution Channel
    • 9.2.6. By Country
  • 9.3. Europe: Country Analysis
    • 9.3.1. France Remdesivir Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Dosage Form
        • 9.3.1.2.2. By Route of Administration
        • 9.3.1.2.3. By Patient Age
        • 9.3.1.2.4. By Application
        • 9.3.1.2.5. By Distribution Channel
    • 9.3.2. United Kingdom Remdesivir Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Dosage Form
        • 9.3.2.2.2. By Route of Administration
        • 9.3.2.2.3. By Patient Age
        • 9.3.2.2.4. By Application
        • 9.3.2.2.5. By Distribution Channel
    • 9.3.3. Italy Remdesivir Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Dosage Form
        • 9.3.3.2.2. By Route of Administration
        • 9.3.3.2.3. By Patient Age
        • 9.3.3.2.4. By Application
        • 9.3.3.2.5. By Distribution Channel
    • 9.3.4. Germany Remdesivir Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Dosage Form
        • 9.3.4.2.2. By Route of Administration
        • 9.3.4.2.3. By Patient Age
        • 9.3.4.2.4. By Application
        • 9.3.4.2.5. By Distribution Channel
    • 9.3.5. Spain Remdesivir Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Dosage Form
        • 9.3.5.2.2. By Route of Administration
        • 9.3.5.2.3. By Patient Age
        • 9.3.5.2.4. By Application
        • 9.3.5.2.5. By Distribution Channel

10. South America Remdesivir Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Dosage Form
    • 10.2.2. By Route of Administration
    • 10.2.3. By Patient Age
    • 10.2.4. By Application
    • 10.2.5. By Distribution Channel
    • 10.2.6. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Remdesivir Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Dosage Form
        • 10.3.1.2.2. By Route of Administration
        • 10.3.1.2.3. By Patient Age
        • 10.3.1.2.4. By Application
        • 10.3.1.2.5. By Distribution Channel
    • 10.3.2. Argentina Remdesivir Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Dosage Form
        • 10.3.2.2.2. By Route of Administration
        • 10.3.2.2.3. By Patient Age
        • 10.3.2.2.4. By Application
        • 10.3.2.2.5. By Distribution Channel
    • 10.3.3. Colombia Remdesivir Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Dosage Form
        • 10.3.3.2.2. By Route of Administration
        • 10.3.3.2.3. By Patient Age
        • 10.3.3.2.4. By Application
        • 10.3.3.2.5. By Distribution Channel

11. Middle East and Africa Remdesivir Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Dosage Form
    • 11.2.2. By Route of Administration
    • 11.2.3. By Patient Age
    • 11.2.4. By Application
    • 11.2.5. By Distribution Channel
    • 11.2.6. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. Iran Remdesivir Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Dosage Form
        • 11.3.1.2.2. By Route of Administration
        • 11.3.1.2.3. By Patient Age
        • 11.3.1.2.4. By Application
        • 11.3.1.2.5. By Distribution Channel
    • 11.3.2. South Africa Remdesivir Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Dosage Form
        • 11.3.2.2.2. By Route of Administration
        • 11.3.2.2.3. By Patient Age
        • 11.3.2.2.4. By Application
        • 11.3.2.2.5. By Distribution Channel
    • 11.3.3. UAE Remdesivir Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Dosage Form
        • 11.3.3.2.2. By Route of Administration
        • 11.3.3.2.3. By Patient Age
        • 11.3.3.2.4. By Application
        • 11.3.3.2.5. By Distribution Channel
    • 11.3.4. Saudi Arabia Remdesivir Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Dosage Form
        • 11.3.4.2.2. By Route of Administration
        • 11.3.4.2.3. By Patient Age
        • 11.3.4.2.4. By Application
        • 11.3.4.2.5. By Distribution Channel
    • 11.3.5. Kuwait Remdesivir Market Outlook
      • 11.3.5.1. Market Size & Forecast
        • 11.3.5.1.1. By Value
      • 11.3.5.2. Market Share & Forecast
        • 11.3.5.2.1. By Dosage Form
        • 11.3.5.2.2. By Route of Administration
        • 11.3.5.2.3. By Patient Age
        • 11.3.5.2.4. By Application
        • 11.3.5.2.5. By Distribution Channel

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Pricing Analysis

15. Patent Analysis

16. Competitive Landscape

  • 16.1. Gilead Sciences, Inc.
  • 16.2. Cipla Ltd.
  • 16.3. Hetero Labs Ltd.
  • 16.4. Meda Pharma SA (VIATRIS Pharmaceuticals Ltd.)
  • 16.5. Dr Reddy's Laboratories Ltd.
  • 16.6. Sun Pharmaceutical Industries Ltd.
  • 16.7. Cadila Healthcare Ltd.
  • 16.8. Jubilant Pharmova Ltd.
  • 16.9. Eva Pharma Ltd.
  • 16.10. Ferozsons Laboratories

17. Strategic Recommendations

18. About Us & Disclaimer

Back to Top
전화 문의
F A Q